NCT00004662View on ClinicalTrials.gov

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

March 31, 1996

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

dehydroepiandrosterone

All Listed Sponsors
collaborator

Northwestern University

OTHER

lead

National Center for Research Resources (NCRR)

NIH